More than 2 years into the pandemic, the issue of deferred care continues to affect the healthcare industry
Concerns about the implications of deferred care continue to grow as healthcare organizations establish their strategies for a post-pandemic landscape.
CMS issues FY23 proposed payment rules for hospices, inpatient psychiatric facilities and inpatient rehabilitation facilities
CMS has released proposed FY23 rules governing prospective payments to hospices, inpatient psychiatric facilities and inpatient rehabilitation facilities.
Staff, patients, benchmarks have the attention of rev cycle leaders
5 takeaways from HFMA’s Revenue Cycle Conference
Claims submitted to HRSA’s COVID-19 funds for uninsured and underinsured patients soon won’t be paid
Funds used to reimburse providers for supplying COVID-19-related services to the uninsured and underinsured will expire soon if Congress doesn’t act.
Healthcare spending projections for the next decade reflect an expectation of steadying trends post-pandemic
CMS actuaries say the healthcare spending spike of 2020 will be tempered across sectors and payers in upcoming years.
Healthcare News of Note: Staffing shortages in hospitals and healthcare settings are ‘actively jeopardizing’ patient safety, says ECRI
Healthcare News of Note for healthcare finance professionals is a roundup of recent news articles: Staffing shortages top the list of patient safety concerns, nearly a third of surveyed nurses said they may leave their direct patient care jobs, and MA plans collected $12 billion more in 2020 than traditional Medicare.
Provider Relief Fund update: Second reporting deadline looms as the fund nears depletion
Healthcare organizations that received Provider Relief Fund payments between July 1 and Dec. 31, 2020, have until Thursday, March 31 to report on their use of those funds.
MedPAC says 2023 hospital payments shouldn’t increase in response to COVID-19
CMS shouldn’t increase Medicare payments to hospitals for the upcoming year beyond the annual update that is based on current law, according to the Medicare Payment Advisory Commission.
Federal funding bill addresses 340B eligibility concerns but not some other points of interest for hospitals
An FY22 appropriations bill allows hospitals to remain in the 340B Drug Pricing Program if their eligibility had been adversely affected by the COVID-19 pandemic.
Healthcare pricing update: 2 experts call for greater regulation
Recent price increases have been slower in healthcare than in the economy at large, but two healthcare economists say the long-term price trends should be addressed through regulation.